Heron Therapeutics, Inc. · NASDAQ:HRTX

Collard Craig A exercised options for 13,797 Heron Therapeutics, Inc. shares (Form 4)

Traded Apr 19, 2026 · Filed Apr 21, 2026

On Apr 19, 2026, Collard Craig A (Director, Chief Executive Officer) exercised options for 13,797 Heron Therapeutics, Inc. shares, leaving 662,052 shares. Filed Apr 21, 2026 (Form 4).

Options exercised
13,797 shares
Holding after
662,052 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 19, 2026Common StockOption exercise13,797662,052Direct

Source

View original at SEC

Related